Adrian Hanson
Research Subjects
Adrian Hanson has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ali Khademhosseini
Terasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, USA
1 shared publication - Alireza Hassani Najafabadi
Department of Pharmaceutical Sciences, University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, OH 45267, USA
1 shared publication - Arne Peirsman
Plastic, Reconstructive and Aesthetic Surgery, University Hospital Ghent, Corneel Heymanslaan 10, Gent, Oost-Vlaanderen, 9000, BELGIUM
1 shared publication - Can Yilgor
Terasaki Institute for Biomedical Innovation, 21100 Erwin St, Woodland Hills, CA 91367, USA
1 shared publication - Christian Umemura
Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90064, USA
1 shared publication - Danial Khorsandi
Terasaki Institute for Biomedical Innovation, Los Angeles, CA, 90064, USA
1 shared publication
Latest Publications
- Open Access
- 29 April 2023
- Published by MDPI AG in Micromachines
- Vol. 14 (5) , 978
Engineered Vasculature for Cancer Research and Regenerative Medicine
Engineered human tissues created by three-dimensional cell culture of human cells in a hydrogel are becoming emerging model systems for cancer drug discovery and regenerative medicine. Complex functional engineered tissues can also assist in the regeneration, repair, or replacement of human tissues. However, one of the main hurdles for tissue engineering, three-dimensional cell culture, and regenerative medicine is the capability of delivering nutrients and oxygen to cells through the vasculatures. Several studies have investigated different strategies to create a functional vascular system in engineered tissues and organ-on-a-chips. Engineered vasculatures have been used for the studies of angiogenesis, vasculogenesis, as well as drug and cell transports across the endothelium. Moreover, vascular engineering allows the creation of large functional vascular conduits for regenerative medicine purposes. However, there are still many challenges in the creation of vascularized tissue constructs and their biological applications. This review will summarize the latest efforts to create vasculatures and vascularized tissues for cancer research and regenerative medicine.
- 29 April 2023
- Published by MDPI AG in Micromachines
- Vol. 14 (5) , 978
Open AccessEngineered Vasculature for Cancer Research and Regenerative Medicine
Engineered human tissues created by three-dimensional cell culture of human cells in a hydrogel are becoming emerging model systems for cancer drug discovery and regenerative medicine. Complex functional engineered tissues can also assist in the regeneration, repair, or replacement of human tissues. However, one of the main hurdles for tissue engineering, three-dimensional cell culture, and regenerative medicine is the capability of delivering nutrients and oxygen to cells through the vasculatures. Several studies have investigated different strategies to create a functional vascular system in engineered tissues and organ-on-a-chips. Engineered vasculatures have been used for the studies of angiogenesis, vasculogenesis, as well as drug and cell transports across the endothelium. Moreover, vascular engineering allows the creation of large functional vascular conduits for regenerative medicine purposes. However, there are still many challenges in the creation of vascularized tissue constructs and their biological applications. This review will summarize the latest efforts to create vasculatures and vascularized tissues for cancer research and regenerative medicine.